Bai YR - Search Results

1

Functional Hexafluoroisopropyl Group Used in the Construction of Biologically Important Pyrimidine Derivatives.

Yuan S, Li X, Zhang YL, Zhou WJ, Du YB, He ZX, Liu HM, Bai YR. Yuan S, et al. Among authors: bai yr. J Org Chem. 2024 Oct 31. doi: 10.1021/acs.joc.4c01749. Online ahead of print. J Org Chem. 2024. PMID: 39480993

2

The mechanism of action and chemical synthesis of FDA newly approved drug molecules.

Shen DD, Zhang YL, Li X, Bai YR, Xiong JF, Seng DJ, Zhang YD, Liu HM, Yuan S, Yang L. Shen DD, et al. Among authors: bai yr. Drug Dev Res. 2024 Sep;85(6):e22260. doi: 10.1002/ddr.22260. Drug Dev Res. 2024. PMID: 39254376 Review.

3

The recent advance and prospect of poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.

Bai YR, Yang WG, Jia R, Sun JS, Shen DD, Liu HM, Yuan S. Bai YR, et al. Med Res Rev. 2024 Aug 24. doi: 10.1002/med.22069. Online ahead of print. Med Res Rev. 2024. PMID: 39180380 Review.

4

A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect.

Bai YR, Yang X, Chen KT, Cuan XD, Zhang YD, Zhou L, Yang L, Liu HM, Yuan S. Bai YR, et al. Eur J Med Chem. 2024 Nov 5;277:116759. doi: 10.1016/j.ejmech.2024.116759. Epub 2024 Aug 10. Eur J Med Chem. 2024. PMID: 39137454 Review.

5

A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects.

Bai YR, Seng DJ, Xu Y, Zhang YD, Zhou WJ, Jia YY, Song J, He ZX, Liu HM, Yuan S. Bai YR, et al. Eur J Med Chem. 2024 Oct 5;276:116706. doi: 10.1016/j.ejmech.2024.116706. Epub 2024 Jul 22. Eur J Med Chem. 2024. PMID: 39053188 Review.

6

[Effect of Biochar on NO₃^--N Transport in Loessial Soil and Its Simulation].

Bai YR, Liu X, Zhang YH, Zhang RY, Ma Y, Wang YQ. Bai YR, et al. Huan Jing Ke Xue. 2024 May 8;45(5):2905-2912. doi: 10.13227/j.hjkx.202305075. Huan Jing Ke Xue. 2024. PMID: 38629552 Chinese.

7

Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer.

Xu X, Sun Z, Liu Q, Zhang Y, Shen L, Zhang C, Lin H, Hu B, Rong L, Chen H, Wang X, Zhao X, Bai YR, Ye Q, Ma X. Xu X, et al. Among authors: bai yr. J Immunother Cancer. 2024 Mar 7;12(3):e008631. doi: 10.1136/jitc-2023-008631. J Immunother Cancer. 2024. PMID: 38458635 Free PMC article.

8

Annual review of PROTAC degraders as anticancer agents in 2022.

Wang X, Qin ZL, Li N, Jia MQ, Liu QG, Bai YR, Song J, Yuan S, Zhang SY. Wang X, et al. Among authors: bai yr. Eur J Med Chem. 2024 Mar 5;267:116166. doi: 10.1016/j.ejmech.2024.116166. Epub 2024 Jan 25. Eur J Med Chem. 2024. PMID: 38281455 Review.

9

Targeting TRPV1 and TRPA1: A feasible strategy for natural herbal medicines to combat postoperative ileus.

Liang Q, Wang JW, Bai YR, Li RL, Wu CJ, Peng W. Liang Q, et al. Among authors: bai yr. Pharmacol Res. 2023 Oct;196:106923. doi: 10.1016/j.phrs.2023.106923. Epub 2023 Sep 13. Pharmacol Res. 2023. PMID: 37709183 Free article. Review.

10

The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.

Bai YR, Yang WG, Hou XH, Shen DD, Zhang SN, Li Y, Qiao YY, Wang SQ, Yuan S, Liu HM. Bai YR, et al. Eur J Med Chem. 2023 Oct 5;258:115606. doi: 10.1016/j.ejmech.2023.115606. Epub 2023 Jun 28. Eur J Med Chem. 2023. PMID: 37402343 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters